Source:http://linkedlifedata.com/resource/pubmed/id/15017354
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-3-12
|
pubmed:abstractText |
Both insulin resistance and dyslipidaemia are determined by genetic and environmental factors. Depending on their expression and their function, gene variants (mutations, polymorphisms) can primarily regulate either insulin action or dyslipidaemia. The purpose of this review is to give some examples from recent studies on gene variants regulating primarily insulin signalling or lipoprotein metabolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0957-9672
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-20
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15017354-Alleles,
pubmed-meshheading:15017354-Genetic Variation,
pubmed-meshheading:15017354-Humans,
pubmed-meshheading:15017354-Hyperlipidemias,
pubmed-meshheading:15017354-Insulin Resistance,
pubmed-meshheading:15017354-PPAR gamma,
pubmed-meshheading:15017354-Phosphoric Diester Hydrolases,
pubmed-meshheading:15017354-Pyrophosphatases,
pubmed-meshheading:15017354-Risk Factors
|
pubmed:year |
2004
|
pubmed:articleTitle |
Gene variants, insulin resistance, and dyslipidaemia.
|
pubmed:affiliation |
Department of Medicine, University of Kuopio, Kuopio, Finland. markku.laakso@kuh.fi
|
pubmed:publicationType |
Journal Article,
Review
|